Effect of the switch status of Helicobacter pylori outer inflammatory protein A on gastric diseases

Sinem Oktem-Okullu1, Tayyip Karaman2, Sümeyye Akcelik-Deveci2

  • 1Department of Medical Microbiology, School of Medicine, Acibadem Mehmet Ali Aydinlar University, Atasehir, Istanbul, 34752, Turkey. sinem.oktem@acibadem.edu.tr.

AMB Express
|October 10, 2023
PubMed

Insights

Helicobacter pylori Outer Inflammatory Protein A (OipA) "On" status is strongly linked to gastric cancer. The conserved FWLHA pentamer is a more reliable marker for OipA status than CT repeat counts.

Area of Science:

  • Microbiology
  • Genetics
  • Oncology

Background:

  • Helicobacter pylori Outer Inflammatory Protein A (OipA) is crucial for bacterial adherence and colonization.
  • OipA expression phase variation is regulated by CT dinucleotide repeats, influencing its role in gastric diseases.
  • Controversy exists regarding the association between OipA 'On' status and gastric pathologies.

Purpose of the Study:

  • To analyze the relationship between OipA phase variation and gastric diseases using a large dataset.
  • To identify reliable markers for determining OipA 'On' status.
  • To investigate the structural basis of OipA function.

Main Methods:

  • Compilation and analysis of 536 oipA DNA sequences from multiple studies (2000-2019) and in-house research.
  • Examination of CT repeat numbers and the conserved FWLHA pentamer for OipA status determination.
  • Bioinformatic analysis, including AlphaFold2 for OipA structure prediction.

Main Results:

  • Absolute conservation of the FWLHA pentamer for OipA 'On' status was identified, proving superior to CT repeat counting.
  • A strong association between OipA 'On' status and gastric cancer was confirmed.
  • AlphaFold2 predicted an OipA structure resembling the autotransporter family.

Conclusions:

  • The study confirms a significant link between OipA 'On' status and severe gastrointestinal diseases, particularly gastric cancer.
  • The FWLHA pentamer serves as a more accurate indicator of OipA 'On' status and its putative autotransporter function than CT repeat numbers.
  • OipA's role in gastric pathogenesis is further elucidated, highlighting its potential as a diagnostic marker.

Related Concept Videos

Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
606
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
354
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
438
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
182
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
151
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
422